Sano Genetics

Sano Genetics is a Cambridge-based company founded in 2017 by three PhD students. The company focuses on advancing precision medicine through a technology-driven platform that streamlines clinical research. It connects pharmaceutical companies, biotech firms, researchers, and patient advocacy groups to enhance participant recruitment and engagement, making the research process more efficient and cost-effective. The platform offers a variety of services, including study design and consulting, recruitment support, prescreening and digital consent, electronic medical record retrieval, and non-invasive DNA testing. Sano Genetics prioritizes patient data ownership and privacy, allowing individuals to control their genetic information. The company also utilizes whole genome sequencing to support research and clinical analysis, particularly for patients with rare or chronic diseases. Sano Genetics has experienced significant growth, including a fivefold increase in annual recurring revenue in 2023 and an expansion of its workforce. It has raised over $22 million in funding to enhance its AI capabilities and broaden its precision trial platform. The company has been recognized as a prominent startup in the UK biotech sector.